The impact of glycerophosphoinositol on FGA and NOTCH3 expression, as well as its effects on cellular viability and apoptosis, support the potential therapeutic application of this compound in COAD treatment. This evidence concerns the gene NOTCH3 and colon adenocarcinoma.